MarketPeel
Insider Trading Intelligence
ER

Elizabeth E. Reed

TVTX
SVP, GC & CORPORATE SECRETARY · TRAVERE THERAPEUTICS, INC. · CIK 0001283303
FILING MIX · LIFETIME38%/62%
BUYS
35
SELLS
56
TOTAL VALUE
$8.37M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
105,211
AVG SELL PX
$31.16
TRADE KIND
SHOWING 91 / 91
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
37 backtested trades · 8 horizons · 60 pending
Forward-return performance of every backtestable P/S trade by Elizabeth E. Reed, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d37+51.35%+0.41%+1.14%-0.73%-1.95%-0.74
14d37+59.46%-0.81%+1.21%-1.78%-1.30%-1.07
30d37+56.76%-0.39%+1.21%-1.38%-0.21%-0.48
60d37(1 pending)+44.44%+4.99%+1.58%+2.12%+0.34%0.53
90d37(7 pending)+46.67%+12.10%+4.42%+7.68%+10.29%1.24
180d37(15 pending)+63.64%-4.46%+6.59%-11.05%-3.23%
1y37(16 pending)+42.86%+21.51%+12.20%+9.31%-8.66%
2y37(21 pending)+81.25%+3.92%+21.06%-17.13%-32.62%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TVTX · 105,211 shares · as of May 6, 2026
039,17878,356117,533156,71120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 35 buys / 56 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,076$43.95$91.2K105,211May 6, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,174$46.65$101.4K107,287May 5, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
4,2504,250May 4, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
20,000$17.96$359.2K125,211May 4, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,5008,500May 4, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
20,0000May 4, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
4,250109,461May 4, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,000$45.00$900.0K105,211May 4, 2026May 6, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,226$41.62$217.5K106,770Apr 15, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,559$42.53$66.3K105,211Apr 15, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
7,500$15.46$116.0K156,711Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,215$41.93$302.5K111,996Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
7,50037,500Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
20,000$17.96$359.2K149,211Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
20,00020,000Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
10,0000Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
10,000$19.08$190.8K129,211Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
37,500$41.07$1.54M119,211Apr 14, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,000119,211Apr 13, 2026Apr 15, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
10,000$15.46$154.6K115,211Apr 1, 2026Apr 2, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
10,00045,000Apr 1, 2026Apr 2, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$30.00$300.0K105,211Apr 1, 2026Apr 2, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$28.09$280.9K105,211Mar 16, 2026Mar 18, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
10,000$19.08$190.8K115,211Mar 16, 2026Mar 18, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
10,00010,000Mar 16, 2026Mar 18, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
10,000$19.08$190.8K115,211Feb 17, 2026Feb 19, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,321$28.26$122.1K105,211Feb 17, 2026Feb 19, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
10,00020,000Feb 17, 2026Feb 19, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,679$27.50$156.2K109,532Feb 17, 2026Feb 19, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
509$32.74$16.7K105,211Feb 4, 2026Feb 4, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,485$32.07$79.7K105,720Feb 4, 2026Feb 4, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
7,175$32.12$230.5K108,205Feb 3, 2026Feb 3, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
66,96066,960Jan 31, 2026Feb 3, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,110115,380Jan 31, 2026Feb 3, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$27.34$273.4K90,270Jan 20, 2026Jan 21, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
10,00030,000Jan 20, 2026Jan 21, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
10,000$19.08$190.8K100,270Jan 20, 2026Jan 21, 2026View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$25.00$250.0K89,878Sep 22, 2025Sep 24, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
10,000$19.08$190.8K99,878Sep 22, 2025Sep 24, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
10,00040,000Sep 22, 2025Sep 24, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,920$21.05$103.6K89,482May 5, 2025May 5, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
Chief Legal Officer and GC
4,9204,920May 2, 2025May 5, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer and GC
4,92094,402May 2, 2025May 5, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,000$23.53$188.2K89,482Feb 12, 2025Feb 12, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
SVP, GC & CORPORATE SECRETARY
8,00097,482Feb 10, 2025Feb 12, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & CORPORATE SECRETARY
8,0000Feb 10, 2025Feb 12, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,951$19.78$177.1K89,482Feb 3, 2025Feb 4, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
58,00058,000Jan 31, 2025Feb 4, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,50098,433Jan 31, 2025Feb 4, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,437$19.46$47.4K76,933Jan 22, 2025Jan 23, 2025View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,387$11.52$50.5K78,633Sep 9, 2024Sep 9, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,75083,020Sep 5, 2024Sep 9, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & CORPORATE SECRETARY
2,590$8.86$22.9K76,270Feb 1, 2024Feb 2, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & CORPORATE SECRETARY
2,174$8.53$18.5K78,860Feb 1, 2024Feb 2, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00081,034Jan 31, 2024Feb 2, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,00065,000Jan 31, 2024Feb 2, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & CORPORATE SECRETARY
2,062$8.96$18.5K56,034Jan 23, 2024Jan 25, 2024View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
1,815$14.71$26.7K58,096Sep 5, 2023Sep 5, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,30059,911Aug 31, 2023Sep 5, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
825$16.59$13.7K56,611May 10, 2023May 12, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,590$22.25$57.6K57,436Feb 1, 2023Feb 2, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
54,50054,500Jan 31, 2023Feb 2, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,25060,026Jan 31, 2023Feb 2, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,7506,750Jan 31, 2023Feb 2, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,062$21.50$44.3K39,776Jan 24, 2023Jan 26, 2023View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
1,050$21.51$22.6K41,838May 12, 2022May 12, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
900$21.51$19.4K42,888May 10, 2022May 12, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,84045,138Jan 31, 2022Feb 2, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,8409,840Jan 31, 2022Feb 2, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,0008,000Jan 31, 2022Feb 2, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
39,36039,360Jan 31, 2022Feb 2, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
1,350$27.40$37.0K43,788Jan 31, 2022Feb 2, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,250$24.98$56.2K35,298Jan 24, 2022Jan 26, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
5,000$27.40$137.0K37,548Jan 11, 2022Jan 12, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,00042,548Jan 10, 2022Jan 12, 2022View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
1,407$17.12$24.1K37,548Aug 17, 2021Aug 17, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,50038,955Aug 13, 2021Aug 17, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
1,625$19.46$31.6K34,455May 12, 2021May 13, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
1,625$19.14$31.1K36,080May 11, 2021May 13, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,250$31.58$71.1K37,705Feb 8, 2021Feb 9, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,250$31.41$70.7K39,955Feb 5, 2021Feb 9, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,500$28.91$72.3K38,380Feb 3, 2021Feb 3, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,50042,205Feb 3, 2021Feb 5, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
675$28.91$19.5K37,705Feb 3, 2021Feb 3, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
2,500$30.75$76.9K41,555Feb 2, 2021Feb 2, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
675$30.75$20.8K40,880Feb 2, 2021Feb 2, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,00044,055Jan 31, 2021Feb 2, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
57,50057,500Jan 21, 2021Jan 25, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00039,055Jan 21, 2021Jan 25, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
688$27.01$18.6K24,055Jan 6, 2021Jan 7, 2021View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
SVP, GC & Corporate Secretary
688$26.65$18.3K24,743Jan 5, 2021Jan 7, 2021View →
Other insiders · TVTX
Loading peer insiders…
About this filer
CIK 0001283303
ROLE
SVP, GC & Corporate Secretary
PRIMARY
TVTX
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001283303DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback